Lisa Tuomi

2.4k total citations
85 papers, 1.8k citations indexed

About

Lisa Tuomi is a scholar working on Otorhinolaryngology, Pulmonary and Respiratory Medicine and Speech and Hearing. According to data from OpenAlex, Lisa Tuomi has authored 85 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Otorhinolaryngology, 31 papers in Pulmonary and Respiratory Medicine and 29 papers in Speech and Hearing. Recurrent topics in Lisa Tuomi's work include Head and Neck Cancer Studies (31 papers), Dysphagia Assessment and Management (29 papers) and Retinal Diseases and Treatments (27 papers). Lisa Tuomi is often cited by papers focused on Head and Neck Cancer Studies (31 papers), Dysphagia Assessment and Management (29 papers) and Retinal Diseases and Treatments (27 papers). Lisa Tuomi collaborates with scholars based in Sweden, United States and Switzerland. Lisa Tuomi's co-authors include Andrew N. Antoszyk, Caterina Finizia, Srinivas R. Sadda, Howard Shapiro, Carol Chung, Pamela Wong, Carl C. Awh, William R. Freeman, Michael Singer and Philip J. Rosenfeld and has published in prestigious journals such as PLoS ONE, Diabetes and Scientific Reports.

In The Last Decade

Lisa Tuomi

76 papers receiving 1.8k citations

Peers

Lisa Tuomi
Michael A. Klufas United States
Alberto Ferreira Switzerland
Inder Paul Singh United States
Mitchell S. Fineman United States
Lydia Chang United Kingdom
Nathan Bromham United Kingdom
Jeffrey Barrett United States
Paulo Eduardo Novaes Brazil
Yuval Yassur Israel
Jenny Jiao United States
Michael A. Klufas United States
Lisa Tuomi
Citations per year, relative to Lisa Tuomi Lisa Tuomi (= 1×) peers Michael A. Klufas

Countries citing papers authored by Lisa Tuomi

Since Specialization
Citations

This map shows the geographic impact of Lisa Tuomi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Tuomi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Tuomi more than expected).

Fields of papers citing papers by Lisa Tuomi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Tuomi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Tuomi. The network helps show where Lisa Tuomi may publish in the future.

Co-authorship network of co-authors of Lisa Tuomi

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Tuomi. A scholar is included among the top collaborators of Lisa Tuomi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Tuomi. Lisa Tuomi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Karlsson, Therese, et al.. (2025). Risk and Health Factors for Temporomandibular Disorders Following Radiotherapy for Head and Neck Cancer. Journal of Oral Rehabilitation. 52(11). 2102–2113.
2.
Frosolini, Andrea, Lisa Tuomi, Olindo Massarelli, et al.. (2025). Translation and Validation of the Gothenburg Trismus Questionnaire-2 into Italian Language. Journal of Clinical Medicine. 14(9). 2949–2949.
3.
Petersson, Kerstin, Caterina Finizia, Nina Pauli, & Lisa Tuomi. (2024). Validation of the Swedish Dynamic Imaging Grade of Swallowing Toxicity for Flexible Endoscopic Evaluation of Swallowing (DIGEST-FEES). Dysphagia. 40(3). 588–595.
4.
5.
Karlsson, Therese, et al.. (2024). Postradiation trismus in head and neck cancer survivors: a qualitative study of effects on life, rehabilitation, used coping strategies and support from the healthcare system. European Archives of Oto-Rhino-Laryngology. 281(7). 3717–3726. 1 indexed citations
6.
Petersson, Kerstin, Caterina Finizia, Nina Pauli, & Lisa Tuomi. (2024). Preventing radiation‐induced dysphagia and trismus in head and neck cancer—A randomized controlled trial. Head & Neck. 47(1). 159–174. 4 indexed citations
7.
8.
Karlsson, Therese, et al.. (2023). Facial pain, health-related quality of life and trismus-related symptoms up to 5 years post-radiotherapy for head and neck cancer. Supportive Care in Cancer. 31(12). 699–699. 4 indexed citations
9.
Johansson, Mia, Caterina Finizia, Josefine Persson, & Lisa Tuomi. (2020). Cost-effectiveness analysis of voice rehabilitation for patients with laryngeal cancer: a randomized controlled study. Supportive Care in Cancer. 28(11). 5203–5211. 9 indexed citations
10.
Khanani, Arshad M., Lauren Hill, & Lisa Tuomi. (2015). Improvement in visual acuity following ranibizumab treatment in neovascular age-related macular degeneration patients with large pigment epithelial detachments: a subgroup analysis of the HARBOR study. Investigative Ophthalmology & Visual Science. 56(7). 5363–5363. 1 indexed citations
11.
Holz, Frank G., Lisa Tuomi, Beiying Ding, & J. Jill Hopkins. (2015). Development of atrophy in neovascular AMD treated with ranibizumab in the HARBOR study. Investigative Ophthalmology & Visual Science. 56(7). 890–890. 5 indexed citations
12.
Tuomi, Lisa, et al.. (2014). Transmyringeal ventilation tube treatment in children: Hearing outcome after 10 years. International Journal of Pediatric Otorhinolaryngology. 79(2). 186–190. 1 indexed citations
13.
Morse, Lawrence S., Linda Yau, Lisa Tuomi, & Jason S. Ehrlich. (2013). Clinically significant improvement in visual acuity and predictors of early vision gains in the RIDE and RISE Phase III trials of ranibizumab for diabetic macular edema. Investigative Ophthalmology & Visual Science. 54(15). 1241–1241. 1 indexed citations
14.
Avery, Robert L., et al.. (2013). Meta-analysis examining the systemic safety profile of intravitreal ranibizumab injections in AMD, RVO and DME. Investigative Ophthalmology & Visual Science. 54(15). 1535–1535. 3 indexed citations
15.
Dreyer, Richard F., et al.. (2013). Early vs Delayed 15-Letter Responders to Ranibizumab Treatment in Year 1 of the Phase III HARBOR Trial. Investigative Ophthalmology & Visual Science. 54(15). 3829–3829. 1 indexed citations
16.
Tuomi, Lisa, Yi Zhang, & Jennifer Visich. (2012). Pharmacokinetics (PK) Of Intravitreal Ranibizumab (RBZ) In Patients With Neovascular Age-related Macular Degeneration (AMD), Retinal Vein Occlusion (RVO), And Diabetic Macular Edema (DMD). Investigative Ophthalmology & Visual Science. 53(14). 4178–4178. 1 indexed citations
17.
Rosenfeld, Philip J., et al.. (2010). Characteristics of Patients Losing Vision after 2 Years of Monthly Dosing in the Phase III Ranibizumab Clinical Trials. Ophthalmology. 118(3). 523–530. 218 indexed citations
18.
Apte, Rajendra S., S. L. Alexander, Erin C. Henry, Pamela Wong, & Lisa Tuomi. (2010). AN OBSERVATIONAL RETROSPECTIVE SUBGROUP ANALYSIS OF VERTEPORFIN PHOTODYNAMIC THERAPY–NAIVE AND PREVIOUSLY TREATED PATIENTS IN THE FOCUS TRIAL. Retina. 31(1). 56–64. 1 indexed citations
19.
Feiner, Leonard, et al.. (2009). Classification and Regression Tree Analysis to Identify Predictive Factors for Visual Acuity Outcomes in Ranibizumab Trials. Investigative Ophthalmology & Visual Science. 50(13). 2358–2358. 1 indexed citations
20.
Rosenfeld, Philip J., et al.. (2008). Lesion Characteristics in Ranibizumab (LUCENTIS®) Treated Patients With a Visual Acuity (VA) Gain or Loss in the MARINA and ANCHOR Trials for Wet Age-Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 49(13). 329–329. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A. Klufas Breakdown of academic impact, for papers by Alberto Ferreira Breakdown of academic impact, for papers by Inder Paul Singh Breakdown of academic impact, for papers by Mitchell S. Fineman Breakdown of academic impact, for papers by Lydia Chang Breakdown of academic impact, for papers by Nathan Bromham Breakdown of academic impact, for papers by Jeffrey Barrett Breakdown of academic impact, for papers by Paulo Eduardo Novaes Breakdown of academic impact, for papers by Yuval Yassur Breakdown of academic impact, for papers by Jenny Jiao
Rankless by CCL
2026